For the Inventor, By the Inventor

Enter assignee name

Barcelona, Spain

Ferrer Internacional, S.a.

USPTO Granted Patents = 47

CIPO Patents = 10

EPO Patents = 23

Trademarks = 11

Forward Citations = 57

Loading Chart...

Loading Chart...

64 inventors (with patents filed for the assignee):

Rafael Foguet (26 out of 29 patents)

Aurelio Sacristan (17 out of 19 patents)

Jose A Ortiz (17 out of 19 patents)

4. Antonio Guglietta (14 out of 21 patents)

5. Albert Palomer (12 out of 15 patents)

6. Josep M Castello (11 out of 11 patents)

7. Manuel M Raga (10 out of 15 patents)

8. Luis Anglada (8 out of 11 patents)

9. Jorge Ramentol (6 out of 6 patents)

10. Ernesto Forne (6 out of 6 patents)

11. Inés Petschen (5 out of 5 patents)

12. Lluis Anglada (5 out of 5 patents)

13. Jordi Bolos (4 out of 4 patents)

14. Santiago Gubert (4 out of 5 patents)

15. Juan Sallares (3 out of 5 patents)

Core Competencies:

Cardiovascular Diseases

Halogenated Pyrazolo Compounds

Pharmaceutical Compositions

Imidazo Compounds

Oxazolidinone Compounds

CDP-Choline

Piperidine Derivatives

Antidepressants

Antithrombotic Agents

Cerebral Ischemia

Alcohol Withdrawal Syndrome

Polymorphs

47 patents: Sort by Forward Citations

1. 10617699 - Oral formulation for the treatment of cardiovascular diseases (2020-04-14),

2. 10072000 - Method of treating insomnia with halogenated pyrazolo[1,5-a]pyrimidines (2018-09-11),

3. 10022363 - Pharmaceutical topical compositions (2018-07-17),

4. 9399014 - Pharmaceutical topical compositions (2016-07-26),

5. 8993562 - Imidazo[1,2-b]pyridazines, processes, uses, intermediates and compositions (2015-03-31),

6. 8753680 - Capsule for the prevention of cardiovascular diseases (2014-06-17),

7. 8545816 - Benzoic acid ester compounds, compositions, uses and methods related thereto (2013-10-01),

8. 8530482 - Halogenated pyrazolo[1,5-A]pyrimidines, processes, uses, compositions and intermediates (2013-09-10),

9. 8507684 - 1-cyclopropyl-8-methyl-7-[5-methyl-6-(methylamino)-3-pyridinyl]-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid salts (2013-08-13),

10. 8227501 - [object Object] (2012-07-24),

11. 8158632 - [object Object] (2012-04-17),

12. 8153789 - Imidazo[1,2-b]pyridazines, processes, uses, intermediates and compositions (2012-04-10),

13. 8106202 - Method for making 1-substituted 1H-imidazo [4,5-C] quinolin-4-amine compounds and intermediates therefor (2012-01-31),

14. 8039476 - Polymorph B of N-{2-Fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a] pyrimidin-7-yl]-phenyl}-N-methyl-acetamide (2011-10-18),

15. 8008486 - [object Object] (2011-08-30),

FERRER INTERNACIONAL, S.A. is a multinational pharmaceutical and healthcare company based in Barcelona, Spain. With over 60 years of experience, we are committed to improving people's health and quality of life. Our mission is to discover, develop, and provide innovative solutions in the areas of pharmaceuticals, medical devices, and consumer healthcare. We strive to deliver high-quality, safe, and effective products to patients and healthcare professionals worldwide. With a strong focus on research and development, we invest in cutting-edge technologies and collaborate with leading scientific institutions. Our portfolio includes a wide range of prescription drugs, over-the-counter medications, and healthcare products. Visit our website to learn more about our company, products, and commitment to healthcare innovation.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 20 2026

47 Patents

#10 in Barcelona

#32 in Spain

#14,440 in the World

Barcelona, Spain

Ferrer Internacional, S.a.

Forward Citations = 57

64 inventors:

Rafael Foguet (26 out of 29 patents)

Aurelio Sacristan (17 out of 19 patents)

Jose A Ortiz (17 out of 19 patents)

4. Antonio Guglietta (14 out of 21 patents)

5. Albert Palomer (12 out of 15 patents)

Please report any incorrect information to support@idiyas.com

Loading…